# A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma

> **NCT06356688** · PHASE2 · RECRUITING · sponsor: **Sun Jing** · enrollment: 30 (estimated)

## Conditions studied

- Locally Advanced Esophageal Squamous Cell Carcinoma
- Neoadjuvant Therapy

## Interventions

- **DRUG:** Paclitaxel Polymeric Micelles for Injection and Cisplatin combined with Cadonilimab

## Key facts

- **NCT ID:** NCT06356688
- **Lead sponsor:** Sun Jing
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06356688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06356688, "A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadonilimab as a Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06356688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*